Gamma-Tocopherol and Docosahexaenoic Acid Decrease Inflammation in Dialysis Patients

Thus, gamma tocopherol and DHA are well-tolerated and reduce selected biomarkers of inflammation in hemodialysis patients. Larger randomized, clinical trials will be required to determine if gamma tocopherol and DHA can reduce cardiovascular complications in hemodialysis patients.